248262-96-6Relevant articles and documents
PYRROLOPYRAZINE DERIVATIVES AS SYK AND JAK INHIBITORS
-
Page/Page column 50, (2011/12/04)
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula (I), wherein the variables Q and R1 and R2 are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
Inhibitors of HCV replication
-
Page/Page column 193-194, (2010/10/20)
Indole compounds of Formula I are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. Different forms and compositions comprising the compounds are also described as well as methods of preparing the compounds.